Dr. Pascal Hänggi, Co-Founder and CSO of Polyneuron Pharmaceuticals AG, a Uni Basel Spin-off

Antibody-Catch - a novel therapeutic approach for autoimmune diseases

Start Date 19.10.2016 - 17:00
Event End 19.10.2016 - 18:00
Location Universität Basel, Pharmazentrum

Antibody-Catch - a novel therapeutic approach for autoimmune diseases